Search

everythinglearnresearchcommunity

for

Search:↓

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Upadacitinib effectively treated severe hair loss in a child.

Imiquimod 5% cream may not work for treating scrotal extramammary Paget disease.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

Dupilumab helps children with alopecia areata regrow hair safely.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Ustekinumab treatment didn't prevent frontal fibrosing alopecia.

New targeted therapies for psoriasis show promise but face challenges like side effects and treatment resistance.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

Psoriasis patients on biologic therapy have a weaker immune response to COVID-19 vaccination than healthy people.

Baricitinib is an effective treatment for severe alopecia areata.

Tofacitinib successfully treated vitiligo in a patient with lupus without side effects.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Dupilumab helped an 11-year-old boy regrow hair and reduce skin rashes.

Apremilast showed mixed results for treating severe alopecia areata.

Adipose stem cell exosomes can effectively reduce facial redness and improve skin health in atopic dermatitis patients.

The IPL device is safe, effective, and has high patient satisfaction for hair removal.

Mycophenolate mofetil can effectively treat autoimmune hepatitis when standard drugs fail.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

JAK inhibitors effectively reduce alopecia areata symptoms in Black patients.

Imiquimod cream activates hair follicle stem cells and causes early hair growth by changing immune cells and certain protein expressions.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Dupilumab users have a higher risk of developing alopecia areata.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.